1. Home
  2. TXG vs WVE Comparison

TXG vs WVE Comparison

Compare TXG & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TXG
  • WVE
  • Stock Information
  • Founded
  • TXG 2012
  • WVE 2012
  • Country
  • TXG United States
  • WVE Singapore
  • Employees
  • TXG N/A
  • WVE N/A
  • Industry
  • TXG Biotechnology: Laboratory Analytical Instruments
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • TXG Industrials
  • WVE Health Care
  • Exchange
  • TXG Nasdaq
  • WVE Nasdaq
  • Market Cap
  • TXG 1.0B
  • WVE 939.3M
  • IPO Year
  • TXG 2019
  • WVE 2015
  • Fundamental
  • Price
  • TXG $8.84
  • WVE $6.15
  • Analyst Decision
  • TXG Buy
  • WVE Strong Buy
  • Analyst Count
  • TXG 15
  • WVE 11
  • Target Price
  • TXG $17.65
  • WVE $20.91
  • AVG Volume (30 Days)
  • TXG 4.2M
  • WVE 1.7M
  • Earning Date
  • TXG 05-08-2025
  • WVE 05-08-2025
  • Dividend Yield
  • TXG N/A
  • WVE N/A
  • EPS Growth
  • TXG N/A
  • WVE N/A
  • EPS
  • TXG N/A
  • WVE N/A
  • Revenue
  • TXG $624,662,000.00
  • WVE $104,939,000.00
  • Revenue This Year
  • TXG $0.45
  • WVE N/A
  • Revenue Next Year
  • TXG $9.00
  • WVE N/A
  • P/E Ratio
  • TXG N/A
  • WVE N/A
  • Revenue Growth
  • TXG N/A
  • WVE N/A
  • 52 Week Low
  • TXG $6.78
  • WVE $4.25
  • 52 Week High
  • TXG $28.25
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • TXG 51.23
  • WVE 38.23
  • Support Level
  • TXG $7.72
  • WVE $5.62
  • Resistance Level
  • TXG $9.79
  • WVE $7.07
  • Average True Range (ATR)
  • TXG 0.54
  • WVE 0.60
  • MACD
  • TXG 0.16
  • WVE -0.01
  • Stochastic Oscillator
  • TXG 45.88
  • WVE 19.13

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: